NCCN publishes translations of guidelines for patients

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The National Comprehensive Cancer Network has published a newly-translated Italian version of the NCCN Guidelines for Patients for stomach cancer, funded by the NCCN Foundation thanks to No Stomach for Cancer.

Over the past year, the NCCN Foundation also worked with the Kidney Cancer Association to translate patient guidelines for kidney cancer into Chinese, Czech, German, and Spanish.

The guidelines are available free-of-charge at NCCN’s website or via through their app. Print copies of the NCCN Guidelines for Patients are available on Amazon.com for a nominal fee.

In 2017 alone, the NCCN Guidelines for Patients were viewed more than eight million times by nearly 400,000 individuals, worldwide. The library currently contains 39 different guidelines, including breast, colon, lung, and prostate cancers.

YOU MAY BE INTERESTED IN

Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. Their catchment areas are contiguous, their faculty and staff members collaborate often, and together their institutions embody the culture of NCI-designated cancer centers. 

In the first meeting of the National Cancer Advisory Board since the inauguration of President Donald Trump, NCI Principal Deputy Director Douglas R. Lowy addressed many of the burning questions the oncology field has for the institute. On indirect costs: NCI will continue to use previously negotiated and approved indirect cost rates, with the exception...

The Cancer Letter staff were finalists for nine 2025 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Journalists—seven for journalism; two for design—and won first place for four. The Cancer Letter’s entries recognized by SPJ include investigative journalism, series, breaking news, features, photojournalism, commentary, illustration, and front page design. This is...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login